300888SZSE

Announcement on Using Idle Self-Owned Funds to Purchase Wealth Management Products

Winner Medical Co., Ltd.··3 pages

✨ AI Summary

The company and its subsidiaries plan to use up to RMB 6 billion of idle self-owned funds to purchase wealth management products. This aims to improve fund utilization and increase returns, without impacting daily operations or posing risks. The proposal requires shareholder approval and is valid until the next annual shareholder meeting.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Securities Code: 300888 Securities Abbreviation: WENJIAN MEDICAL Announcement No.: 2026-004

WENJIAN MEDICAL PRODUCTS CO., LTD. Announcement on Using Idle Self-Owned Funds to Purchase Wealth Management Products

The Company and the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed herein, and are free from any false records, misleading statements, or material omissions.

Key Information Prompt:

  1. Investment Type: Wealth management products with high safety, good liquidity, and controllable risks, including but not limited to bank wealth management products, structured deposits, trust products, and other wealth management targets and methods approved by the Company's internal decision-making procedures.
  2. Investment Amount: Not exceeding RMB 6 billion.
  3. Special Risk Prompt: Risks that may be faced by the Company in entrusting wealth management include, but are not limited to, financial market volatility, unpredictable returns, liquidity risk, and operational risk. Investors are kindly requested to pay close attention to investment risks.

WENJIAN MEDICAL PRODUCTS CO., LTD. (hereinafter referred to as the "Company") held the tenth meeting of the Fourth Board of Directors on April 20, 2026, and deliberated and passed the "Proposal on Using Idle Self-Owned Funds to Purchase Wealth Management Products." It was agreed that the Company and its holding subsidiaries, while ensuring daily operating capital needs and capital safety, would use idle self-owned funds with an amount not exceeding RMB 6 billion (inclusive) to purchase wealth management products. The validity period of the above quota and resolution shall be from the date of approval by the Company's 2025 Annual Shareholders' Meeting to the date of the 2026 Annual Shareholders' Meeting. Within the above quota and period, the funds can be used in a revolving manner. This proposal is still subject to approval by the Company's 2025 Annual Shareholders' Meeting. The specific details are hereby announced as follows:

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.

Sign in to read moreSee Pro pricing